The Epidemic That Never Was While I was researching the history of Swine Flu in America, I came across this great piece, written for The Trentonian, by Paul Mickle City Editor at Capitol City Publishing Company, Inc. I was a personal witness to the government induced, 'Return … [Read more...] about A Look Back In Time…1976 Swine Flu Out Break
Influenza A Virus H1N1 Strain
Is There an Upside to the Swine Flu Pandemic?
Big Pharma stockholders think so San Diego-based Vical, a firm who is developing an H1N1 vaccine under an agreement with the U.S. Navy saw company shares climb 45 cents, to $2.65 on positive clinical trial news this week. Vical researches and develops biopharmaceutical … [Read more...] about Is There an Upside to the Swine Flu Pandemic?
Epidemiologists Can’t Determine Why Some People are killed by H1N1
Swine Flu's Impact Still A Mystery Around the world, vaccine manufactures are rushing new swine flu (H1N1) vaccines into clinic trials and booking pre-orders from worried Public Health officials, while epidemiologists are still puzzling out how the new flu works and why many … [Read more...] about Epidemiologists Can’t Determine Why Some People are killed by H1N1
Health and Human Services Reports 2009 H1N1Vaccine Development Activities
Overview of H1N1 (Swine Flu) influenza virus The newly emergent 2009 H1N1 influenza virus is a novel virus with pandemic potential. Consistent with the National Strategy for Pandemic Influenza, HHS is committing funds for the production of pilot lots for clinical studies, as … [Read more...] about Health and Human Services Reports 2009 H1N1Vaccine Development Activities
FDA Has Issued Emergency Use Authorizations for Two Antiviral Treatments — Tamiflu (oseltamavir) and Relenza (zanamivir)
Stockpiled Antivirals at or Nearing ExpirationDuring this public health emergency, the FDA has issued Emergency Use Authorizations that expand access to medical products that may become necessary. Two antiviral treatments covered by Emergency Use Authorizations, Tamiflu … [Read more...] about FDA Has Issued Emergency Use Authorizations for Two Antiviral Treatments — Tamiflu (oseltamavir) and Relenza (zanamivir)